iStent as a solo procedure for glaucoma patients: A systematic review and meta-analysis

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Malvankar Mehta, Monali S ^a   Chen, Yufeng Nancy ^a   Iordanous, Yiannis ^a   Wang, Wan Wendy ^a   Costella, John ^b   Hutnik, Cindy M L ^a  

^a WESTERN UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGLAUCOMA AGENT; ANTIHYPERTENSIVE AGENT;

ARTICLE; CATARACT; CONJUNCTIVAL HEMORRHAGE; EYE INFLAMMATION; FOLLOW UP; GLAUCOMA; GLAUCOMA SURGERY; HUMAN; HYPHEMA; IN-STENT RESTENOSIS; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; IRIS DISEASE; META ANALYSIS; META ANALYSIS (TOPIC); MINIMALLY INVASIVE GLAUCOMA SURGERY; MINIMALLY INVASIVE SURGERY; MULTICENTER STUDY (TOPIC); OPHTHALMOLOGICAL IMPLANT; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); STENT MALAPPOSITION; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); TRABECULAR MICRO BYPASS STENT; TREATMENT OUTCOME; AGED; CATARACT EXTRACTION; DRUG EFFECTS; LENS; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; STENT;

AGED; ANTIHYPERTENSIVE AGENTS; CATARACT; CATARACT EXTRACTION; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; LENS, CRYSTALLINE; PROSPECTIVE STUDIES; STENTS; TREATMENT OUTCOME;

EID: 84938594568     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128146     Document Type: Article

References (43)

1. International Federation on Ageing (2013) The High Cost of Low Vision: The Evidence on Ageing and the Loss of Sight. Executive Summary: International Federation on Ageing.
2. Glaucoma Research Foundation (2013) Glaucoma Facts and Stats.
3. WHO Media Centre (2013) Visual impairment and blindness. World Health Organization.
4. American Academy of Ophthalmology (AAO) (2011) Eye Health Statistics American Academy of Ophthalmology.
5. The National Coalition for Vision Health (2010) Vision Loss in Canada 2011.
6. Glaucoma Research Society of Canada Quick Facts.
7. Quigley HA, Broman AT (2006) The number of people with glaucoma worldwide in 2010 and 2020. British Journal of Ophthalmology 90:262-267. PMID: 16488940
8. Bates DM, Watts DG (1988) Nonlinear regression: iterative estimation and linear approximations: Wiley Online Library.
9. Motulsky H (2004) Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting: A Practical Guide to Curve Fitting: Oxford University Press.
10. Ratkowsky DA, Giles DEA (1990) Handbook of nonlinear regression models: Marcel Dekker New York.
11. Foundation BrightFocus (2013) Glaucoma Facts and Statistics.
12. Fingeret M (1998) Glaucoma medications, glaucoma therapy, and the evolving paradigm. Journal of the American Optometric Association 69:115-121. PMID: 9549260
13. Kass MA, Gordon M, Morley RE Jr, Meltzer DW, Goldberg JJ (1987) Compliance with topical timolol treatment. American journal of ophthalmology 103:188. PMID: 3812621
14. Robin AL, Novack GD, Covert DW, Crockett RS, Marcic TS (2007) Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use. American journal of ophthalmology 144:533-540. e532. PMID: 17686450
15. Okeke CO, Quigley HA, Jampel HD, Ying G-S, Plyler RJ, Yuzhen J, et al. (2009) Adherence with topical glaucoma medication monitored electronically: theTravatan Dosing Aid Study. Ophthalmology 116:191-199. doi: 10.1016/j.ophtha.2008.09.004 PMID: 19084273
16. Tsai JC (2009) A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology 116:S30-S36. doi: 10.1016/j.ophtha.2009.06.024 PMID: 19837258
17. Stone JL, Robin AL, Novack GD, Covert DW, Cagle GD (2009) An objective evaluation of eyedrop instillation in patients with glaucoma. Archives of ophthalmology 127:732. doi: 10.1001/archophthalmol. 2009.96 PMID: 19506189
18. Kholdebarin R, Campbell RJ, Jin Y-P, Buys YM (2008) Multicenter study of compliance and drop administration in glaucoma. Canadian Journal of Ophthalmology/Journal Canadien d'Ophtalmologie 43:454-461. doi: 10.1139/i08-076 PMID: 18711461
19. Baudouin C, Liang H, Hamard P, Riancho L, Creuzot-Garcher C, Warnet JM, et al. (2008) The ocular surface of glaucoma patients treated over the long term expresses inflammatory markers related to bothT-helper 1 and T-helper 2 pathways. Ophthalmology 115:109-115. PMID: 17532048
20. Ammar DA, Noecker RJ, Kahook MY (2011) Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells. Advances in therapy 28:501-510. doi: 10.1007/s12325-011-0029-x PMID: 21603985
21. Leung EW, Medeiros FA, Weinreb RN (2008) Prevalence of ocular surface disease in glaucoma patients. Journal of glaucoma 17:350-355. doi: 10.1097/IJG.0b013e31815c5f4f PMID: 18703943
22. Everitt DE, Avorn J (1990) Systemic effects of medications used to treat glaucoma. Annals of internal medicine 112:120-125. PMID: 1967209
23. Muller ME, Van Der Velde N, Krulder JWM, Van Der Cammen TJM (2006) Lesson of the week: Syncope and falls due to timolol eye drops. BMJ: British Medical Journal 332:960. PMID: 16627515
24. Center for Devices and Radiological Health (2015) Premarket Studies of Implantable Minimally Invasive Glaucoma Surgical (MIGS) Devices.
25. Vandewalle E, Zeyen T, Stalmans I (2009) The iStent trabecular micro-bypass stent: a case series. Bulletin de la Societe Belge d Ophtalmologie 311:23. PMID: 19621551
26. Saheb H, Ahmed I I K (2012) Micro-invasive glaucoma surgery: current perspectives and future directions. Current Opinion in Ophthalmology 23:96-104. doi: 10.1097/ICU.0b013e32834ff1e7 PMID: 22249233
27. Nichamin LD (2009) Glaukos iStent trabecular micro-bypass. Middle East African journal of ophthalmology 16:138. doi: 10.4103/0974-9233.56227 PMID: 20142980
28. Francis BA, Singh K, Lin SC, Hodapp E, Jampel HD, Samples JR, et al. (2011) Novel glaucoma procedures: a report by the American Academy of Ophthalmology. Ophthalmology 118:1466-1480. doi: 10. 1016/j.ophtha.2011.03.028 PMID: 21724045
29. Spiegel D, Wetzel W, Haffner DS, Hill RA (2007) Initial clinical experience with the trabecular micro-bypass stent in patients with glaucoma. Advances in therapy 24:161-170. PMID: 17526473
30. Charters L. (2013) MIGS with stents may benefit OAG. Ophthalmology Times. San Francisco: Advanstar Communications Inc. pp. 1. doi: 10.1186/1687-9856-2013-1 PMID: 23351530
31. Buchacra O, Duch S, Milla E, Stirbu O (2011) One-year analysis of the iStent trabecular microbypass in secondary glaucoma. Clinical ophthalmology (Auckland, NZ) 5:321. doi: 10.2147/OPTH. S15025 PMID: 21468340
32. Buznego C (2008) Trabecular micro-bypass stent for glaucoma. Tech Ophthalmol 6:114-118.
33. Samuelson TW, Katz LJ, Wells JM, Duh Y-J, Giamporcaro JE (2011) Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology 118:459-467. doi: 10.1016/j.ophtha.2010.07.007 PMID: 20828829
34. Fea AM (2010) Phacoemulsification versus phacoemulsification with micro-bypass stent implantation in primary open-angle glaucoma: randomized double-masked clinical trial. Journal of Cataract & Refractive Surgery 36:407-412.
35. Spiegel D, Kobuch K (2002) Trabecular meshwork bypass tube shunt: initial case series. British journal of ophthalmology 86:1228-1231. PMID: 12386074
36. Iordanous Y, Kent JS, Hutnik CM, Malvankar-Mehta MS (2013) Projected Cost Comparison of Trabectome, iStent, and Endoscopic Cyclophotocoagulation Versus Glaucoma Medication in the Ontario Health Insurance Plan. Journal of glaucoma.
37. Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Annals of internal medicine 151:264-269. PMID: 19622511
38. Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. Journal of epidemiology and community health 52:377-384. PMID: 9764259
39. Voskanyan L, Garcia-Feijoo J, Belda JI, Fea A, Junemann A, Baudouin C (2014) Prospective, Unmasked Evaluation of the iStent Inject System for Open-Angle Glaucoma: Synergy Trial. Advances in therapy 31:189-201. doi: 10.1007/s12325-014-0095-y PMID: 24452726
40. Ahmed SH, Voskanyan L (2012) Prospective, Randomized MIGS Study of One, Two or Three Trabecular Micro-Bypass Stents and Travoprost in Open-Angle Glaucoma. European Society of Cataract and Refractive Surgeons. Milan, Italy. doi: 10.1016/j.jcrs.2012.03.006 PMID: 22541829
41. Singh H. GS (2012) iStent glaucoma device: experience at CHUM. European Glaucoma Society Congress. Copenhagen.
42. Zhang W, Po ALW, Dua H, Azuara-Blanco A (2001) Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension. British journal of ophthalmology 85:983-990. PMID: 11466259
43. Egger M, Smith GD, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Bmj 315:629-634. PMID: 9310563